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Fetal growth plays a role in programming of adult cardiometabolic
disorders, which in men, are associated with lowered testosterone
levels. Fetal growth and fetal androgen exposure can also pre-
determine testosterone levels in men, although how is unknown,
because the adult Leydig cells (ALCs) that produce testosterone do
not differentiate until puberty. To explain this conundrum, we
hypothesized that stem cells for ALCs must be present in the fetal
testis and might be susceptible to programming by fetal androgen
exposure during masculinization. To address this hypothesis, we
used ALC ablation/regeneration to identify that, in rats, ALCs de-
rive from stem/progenitor cells that express chicken ovalbumin
upstream promoter transcription factor II. These stem cells are abun-
dant in the fetal testis of humans and rodents, and lineage tracing in
mice shows that they develop into ALCs. The stem cells also express
androgen receptors (ARs). Reduction in fetal androgen action
through AR KO in mice or dibutyl phthalate (DBP) -induced reduc-
tion in intratesticular testosterone in rats reduced ALC stem cell
number by ∼40% at birth to adulthood and induced compensated
ALC failure (low/normal testosterone and elevated luteinizing hor-
mone). In DBP-exposed males, this failure was probably explained
by reduced testicular steroidogenic acute regulatory protein expres-
sion, which is associated with increased histone methylation
(H3K27me3) in the proximal promoter. Accordingly, ALCs and ALC
stem cells immunoexpressed increased H3K27me3, a change that
was also evident in ALC stem cells in fetal testes. These studies
highlight how a key component of male reproductive development
can fundamentally reprogram adult hormone production (through
an epigenetic change), which might affect lifetime disease risk.
adult Leydig stem/progenitor cells | compensated Leydig cell failure |
GATA4 | ethane dimethane sulfonate
Evidence that altered fetal growth/development can funda-mentally alter the risk of health disorders in adulthood and
perhaps, future generations continues to grow (1). Such fetal
programming applies to common disorders encapsulated in the
metabolic syndrome (2), which are interlinked in adult men with
low testosterone levels (3). Large studies from the United States
(4) and Europe (5, 6) also show that testosterone levels in men of
all ages are declining with later year of birth. Aging is itself as-
sociated with declining testosterone levels and a high incidence of
primary/compensated hypogonadism (7–9). Because low testoster-
one levels are also associated with generalized proinflammatory
changes (10, 11), frailty, and risk of dying in aging men (12), what
determines an adult man’s testosterone level is of fundamental
importance.
There is also evidence from human (13, 14) and animal ex-
perimental (15) studies that fetal programming can influence
adult testosterone levels, particularly that reduced fetal andro-
gen exposure leads to lower adult male testosterone levels (14,
15). This data fits with growing evidence that subtle deficiency in
fetal androgens is a major determinant of adult male reproductive
disorders, such as low sperm production (16, 17), and might
explain why low sperm counts are often associated with com-
pensated Leydig cell failure in men (18). However, the mech-
anisms through which fetal events could influence adult
testosterone levels are unknown.
Adult Leydig cells, the main source of blood testosterone in
adult males, do not develop until puberty; the only Leydig cells
present in the fetal testis are a different fetal generation (19–21).
Consequently, adult Leydig cells must develop from stem/pro-
genitor cells (22, 23). Numerous studies in rodents have in-
vestigated how adult Leydig cells differentiate from progenitor
cells at puberty and have identified a number of factors involved
(19, 22, 24–29). However, such studies focus around the period
when stem/progenitor cells have started along the differentiation
pathway into adult Leydig cells. What might affect the stem/
progenitor cells before this point, such as during fetal life, has
not been studied, primarily because there is no agreed defining
marker for such cells before they commence differentiation. In
this regard, Qin et al. (30) showed that inducible KO of chicken
ovalbumin upstream promoter transcription factor II (Coup-tfII;
also termed Nr2f2) in prepubertal male mice resulted in failure
of adult Leydig cells to develop. We, therefore, hypothesized
that COUP-TFII–expressing non-Leydig interstitial cells in the
testis may be the stem cells for adult Leydig cells and that effects
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on these cells might explain how fetal events can impact adult
testosterone levels (adult Leydig cell function).
We presently show, through ablation/regeneration models,
that adult Leydig cells in rats/mice do, indeed, derive from
COUP-TFII–expressing stem cells that are numerous in the fetal
testes of humans, marmosets, and rodents. We show that these
stem cells express androgen receptors (ARs) and that experi-
mental reduction of androgen production/action in fetal life in
mice/rats through transgenic and chemical manipulations results
in corresponding reductions in stem cell numbers in adulthood,
which are accompanied by compensated adult Leydig cell failure.
We also show a potential mechanism through which this pro-
gramming of compensated adult Leydig cell failure might occur,
namely altered histone methylation (H3K27me3) at the gene
promoter for steroidogenic acute regulatory protein (StAR).
Thus, our findings show how fetal androgen deficiency can ad-
versely program adult Leydig cell function, which in a human
context, has implications for aging, general wellbeing, and lon-
gevity of men.
Result
Identification of Adult Leydig Stem Cells by Ablation/Regeneration.
Before we could investigate how fetal events might program
adult Leydig cell function, we had to have a means of identifying
the stem/progenitor cells from which adult Leydig cells derive.
To do so, we used ethane dimethane sulfonate (EDS) -induced
ablation and regeneration of Leydig cells, an established model
for studying adult Leydig cell differentiation in rats (31, 32).
After complete adult Leydig cell ablation by EDS (Fig. 1) and
the consequent reduction in blood testosterone and elevation of
blood luteinizing hormone (LH) levels (Fig. S1), there was re-
generation of identifiable new adult Leydig (3β-HSD+) cells
from ∼14 d post-EDS, with recovery to normal adult Leydig cell
numbers by 5 wk (Fig. 1). In controls, most adult Leydig
(3β-HSD+) cells expressed COUP-TFII in their nuclei as did
regenerating adult Leydig cells (Fig. 1). Up to 1 wk post-EDS,
when no identifiable adult Leydig cells were present, abundant
cells with mainly spindle-shaped nuclei that expressed COUP-
TFII were present. We hypothesized that adult Leydig cells
regenerated from these presumptive stem cells. The number
of putative stem (COUP-TFII+/3β-HSDneg) cells declined sig-
nificantly over the 5-wk period post-EDS, consistent with some
differentiating into adult Leydig cells (Fig. 1). However, there
are other cell types present in or bordering the interstitium, such
as macrophages, pericytes, endothelial cells, and peritubular
myoid cells, which are alternative sources of regenerating adult
Leydig cells, although of these cell types, only the peritubular
myoid cells express COUP-TFII (33).
We, therefore, used immunohistochemistry for cell-selective
markers of macrophages (CD68), pericytes (CD146), endothelial
cells (CD31), and peritubular myoid cells [smooth muscle actin
(SMA)] plus staining for COUP-TFII and 3β-HSD at day 6 after
EDS injection. We found no evidence that regenerating adult
Leydig cells coexpressed any of these cell-selective markers other
than COUP-TFII (Fig. S2). We then compared the expression
profile of adult Leydig cells (in controls) with the adult Leydig
stem cells using a range of factors expressed in adult Leydig cells
and/or reported in immature adult Leydig cells. However, of the
factors investigated, only COUP-TFII and AR were shared by
adult Leydig cells and their stem cells (Fig. S2).
Platelet-derived growth factor-α action through its receptor
(PDGFRα) is important in adult Leydig cell differentiation from
progenitors (27, 29). We found PDGFRα expression in occa-
sional COUP-TFII+ stem cells at 6 d after EDS (Fig. S3), but
in control adult (Fig. S3) and fetal testes (Fig. 3), expression of
PDGFRα in COUP-TFII+ stem cells was rare. We examined
expression of GATA4, which is essential for fetal Leydig cell
development (34) and expressed in mouse (35) and human (36)
adult Leydig cells. At 6–14 d after EDS, a proportion of adult
Leydig stem/progenitor cells (COUP-TFII+), located in peri-
tubular or other regions, coexpressed GATA4, whereas such cells
(COUP-TFII+/GATA4+) were rarely evident in control testes (Fig.
2). At 14–21 d after EDS, these GATA4-expressing stem/progenitor
cells differentiated into adult Leydig cells, which was indicated by
coexpression of 3β-HSD (Fig. 2). We confirmed that this sequence
mimicked normal puberty (Fig. 2). Thus, at age 10 d (before pu-
berty), virtually all adult Leydig stem cells (COUP-TFII+) were
GATA4neg, but at initiation of puberty (day 15), GATA4 expression
Fig. 1. Adult Leydig cell regeneration from COUP-TFII+ stem cells after EDS
induced Leydig cell ablation in adult rats. (Top Left) In controls, adult Leydig
stem cells are identified by their COUP-TFII nuclear staining (green; white
arrow), whereas adult Leydig cells, which also express COUP-TFII, are stained
with the cytoplasmic steroidogenic enzyme marker 3β-HSD (red; yellow ar-
rowhead). (Top Right) Six days after EDS injection, Leydig cells are absent,
but COUP-TFII+ Leydig stem cells (green nuclei) remain (white arrow).
(Middle Left) By EDS + 14 d, some spindle-shaped COUP-TFII+ Leydig stem
cells (yellow arrowhead) have acquired 3β-HSD+ staining (red), marking
onset of adult Leydig cell regeneration. (Middle Right) By 21 d, numerous
COUP-TFII+ adult Leydig cells have regenerated. (Bottom, graph) Quantifi-
cation of Leydig stem cells (COUP-TFII+/3β-HSDneg) and adult Leydig cells
(COUP-TFII+/3β-HSD+) at various times after EDS is shown in the graph. Bars
show means ± SEMs for n = 5–7 rats per group. *P < 0.05, ***P < 0.001
compared with vehicle group (time 0). Leydig stem cell numbers decline sig-
nificantly by EDS + 5 wk. Images are representative of three independent
experiments. Insets show higher magnifications of cells in transition from stem
cells to adult Leydig cells. Dashed lines are the outlines of seminiferous tubules.
(Scale bars: 20 μm; Middle Right, 10 μm.)
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was evident in a proportion of them; by day 25, they had begun to
transform into adult Leydig (3β-HSD+) cells (Fig. 2). In contrast,
virtually no COUP-TFII+ stem cells in the fetal testis expressed
GATA4, which was confined to the nuclei of Sertoli and fetal
Leydig cells (Fig. 3). These studies confirmed our hypothesis that
COUP-TFII–expressing non-Leydig interstitial cells must be the
stem cell population from which adult Leydig cells differentiate.
Fetal Origin of Adult Leydig Stem Cells and Species Conservation. In
fetal testes of humans, marmosets, rats, and mice, adult Leydig
stem (COUP-TFII+/3β-HSDneg) cells were the most abundant
cell type in the interstitium, and the majority of these cells
coexpressed AR (Fig. 3). To confirm that COUP-TFII is a
marker of the adult Leydig stem cell population in fetal life, we
used transgenic lineage tracing. Screening of several transgenic
Cre Recombinase mouse lines bred to a Cre-inducible YFP re-
porter gene (37) showed that the adipocyte protein 2 (aP2) Cre
Recombinase (37) induced YFP expression, coincident with
COUP-TFII, in adult Leydig stem cells when examined at birth
(Fig. 4). Follow-up analysis showed that this fetally induced YFP
expression was restricted to Leydig cells in adulthood (Fig. 4),
confirming that COUP-TFII marks an interstitial stem cell pop-
ulation (3β-HSDneg) that later develops into adult Leydig cells.
Hereafter, we refer to the whole population of these cells as stem
cells to avoid confusion with Leydig progenitor cells described in
the literature, which we would consider as (PDGFRα+/GATA4+)
cells just entering the Leydig cell differentiation pathway (27, 29).
It is unclear if all these stem cells can develop into adult Leydig
cells or only a subpopulation. However, because the adult Leydig
stem cells coexpressed AR (Fig. 3), we investigated if fetal an-
drogen deficiency might affect the development of these cells.
ArKO Affects Development of Adult Leydig Stem Cells. There is no
means of specifically targeting KO of Ar in the adult Leydig stem
cells, because the only presently known markers are COUP-TFII
and AR, both of which are also expressed in peritubular myoid
cells, and KO of Ar in the latter has phenotypic consequences,
including on adult Leydig cells (38, 39). We, therefore, in-
vestigated development of adult Leydig stem cells in complete
ArKO mice. The results showed that, at birth and through
postnatal life into adulthood, the number of adult Leydig stem
cells was reduced by ∼40% in ArKO males compared with WT
controls (Fig. 5). There was a parallel reduction in adult Leydig cell
numbers in ArKO males, and they exhibited compensated Leydig
cell failure based on gross distortion of their blood LH to testos-
terone ratio compared with controls (Fig. 5). In contrast, cell-
selective KO of Ar in Sertoli (SCArKO) or peritubular myoid cells
(PTMArKO) had no significant effect on adult Leydig stem cell
numbers (Fig. S4). Although these findings suggest that androgen
action on adult Leydig stem cells is important for their normal
development, Ar is deleted in other cell types, and all testes are
cryptorchid in ArKOs, which are confounding factors. Therefore,
we used a rat model in which intratesticular testosterone in the
fetus was experimentally reduced (33) and investigated if similar
effects on adult Leydig cell/stem cell development occurred, which
was evident in ArKOs.
Reduction in Fetal Intratesticular Testosterone Impairs Development
of Adult Leydig Stem Cells. Treatment of pregnant rats from em-
bryonic (e)13.5 to e21.5 with 500 mg/kg per day dibutyl phthalate
(DBP) suppresses intratesticular testosterone (ITT) by 50–70%
between e17.5 and e21.5 (33), which is confirmed presently at
e21.5 (Fig. 6). This suppression was associated with a ∼40% re-
duction in adult Leydig stem cell number at e21.5 compared with
controls, a deficit maintained through postnatal life into adult-
hood (Fig. 6). In contrast to ArKOs, DBP treatment did not alter
final adult Leydig cell number (Fig. 6). Despite normal Leydig cell
numbers and significantly raised blood LH levels in DBP-exposed
males in adulthood, blood testosterone levels were significantly
reduced, resulting in a distorted LH to testosterone ratio com-
pared with controls, indicative of compensated Leydig cell failure
(Fig. 6). These results suggest that fetal ITT affects adult Leydig
stem cell number and their functional competence when they
differentiate into adult Leydig cells. Regarding the former, the
number of adult Leydig stem (COUP-TFII+/3β-HSDneg) cells
increased 17-fold from e17.5 [0.16 ± 0.03 × 106 (mean ± SEM),
Fig. 2. Expression of GATA4 in COUP-TFII+ Leydig stem cells is an early step
in their differentiation into adult Leydig cells. Results are shown during
Leydig cell regeneration (Top and Middle) after EDS and (Bottom) during
normal puberty. (Top Left) In adult controls, GATA4 expression (red) is
confined to nuclei of Sertoli cells (asterisk) and 3β-HSD+ (blue) Leydig cells
(white arrowheads). COUP-TFII–expressing Leydig stem cells (green) are
GATA4neg. (Top Right) Six days after EDS, Leydig cells are absent, but GATA4
has switched on in some Leydig stem cells (yellow arrows; coexpression of
green and red in nuclei). (Middle Left) At EDS + 14 d, some of the GATA4+
stem cells have switched on 3β-HSD (blue), and (Middle Right) by day 21,
they have differentiated into adult Leydig cells. Cells coexpressing GATA4,
3β-HSD, and COUP-TFII are labeled with white arrows, but note that, for
technical reasons, COUP-TFII expression in mature adult Leydig cells is often
not evident in these images, whereas it is in other images that do not involve
double immunostaining for GATA4 (Fig. 1). (Bottom Left) At the start of
normal puberty (Pnd15), coexpression of GATA4 in COUP-TFII+ Leydig stem
cells is common (yellow arrows), and (Bottom Right) by Pnd25, many of these
cells are also 3β-HSD+ (white arrows). Images are representative of three to
five animals for three independent experiments. Insets show higher mag-
nifications of protein expression changes in Leydig stem cells during their
differentiation into Leydig cells.
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n = 4] to e21.5 (2.81 ± 0.24 × 106, n = 7) in control rats (this
study) when ITT is high/increasing (33, 40).
Potential Mechanism for Fetal Programming of Compensated Adult
Leydig Cell Failure. We used the rat DBP model to investigate
expression of six genes in the steroidogenic pathway in the adult
testis (Fig. 7). Because we used scrotal and cryptorchid testes
from DBP-exposed animals for these studies, we used a control
gene (Sox9) expressed specifically in Sertoli cells to correct ex-
pression of the target genes, because Leydig cell mRNAs would
be overrepresented in cryptorchid vs. scrotal testes because of
massive germ cell loss in the former. Sox9 was chosen, because
adult Sertoli cell number is unchanged in DBP-exposed animals,
irrespective of whether testes are scrotal or cryptorchid (41). In
DBP-exposed animals, expression of Lhcgr, Cyp11a1, Cyp17a1,
and 17β-hsd3 were unchanged, whereas expression of StAR and
3β-hsd were both significantly reduced compared with controls
(Fig. 7). Because StAR is one of the factors involved in choles-
terol transport into the mitochondrion (42), which is rate-limit-
ing for steroidogenesis (43, 44), this change was considered the
most significant.
For fetal androgen action on stem cells to alter subsequent
adult Leydig cell function through repression of StAR tran-
scription, we considered an epigenetic mechanism likely. Altered
methylation of the proximal-1 promoter region of StAR is crucial
for regulating its expression (45–47) and conserved across spe-
cies (48). Because H3K27me3 is an established transcriptional
repressor (49–51), including of StAR (47), we investigated if the
level of H3K27me3 upstream of the coding region of StAR was
altered using a ChIP assay (47, 51).
Our ChIP results showed a significant increase in H3K27me3
localization to the StAR proximal promoter in adult testes of
DBP-exposed animals compared with controls (Fig. 8). This in-
crease in repressive H3K27me3 could account for reduced StAR
expression. Using an antibody against H3K27me3, we showed
that a proportion of Leydig cells in DBP-exposed rats at post-
natal day 25 (Pnd25) and in adulthood showed expression of
H3K27me3 in their nuclei, whereas it was minimal/absent in
controls at this antibody dilution (Fig. 9); a similar difference was
Fig. 3. Presence of adult Leydig stem cells (white arrows) expressing COUP-
TFII (green) in their nuclei in fetal testes of different species (rows 1 and 2)
and their protein expression phenotype (rows 3 and 4). In rows 1 and 2, red
indicates 3β-HSD [fetal Leydig cells (LCs)], and blue indicates SMA (asterisks
are seminiferous cords). Rows 3 and 4 show that, whereas most adult
Leydig stem (COUP-TFII+) cells lack expression of PDGFRα and GATA4
(white arrows), most adult Leydig stem cells coexpress (white arrowheads)
the AR (red). In rows 3 and 4, blue indicates 3β-HSD (fetal LC). Yellow
arrows show potential PDGFRα+ adult Leydig stem cells. Images are rep-
resentative of three to five animals from three independent experiments.
(Scale bars: 20 μm.)
Fig. 4. COUP-TFII is a marker of the adult Leydig stem population, which is
evident from the transgenic lineage tracing of adult Leydig cells. (Upper) At
birth, the aP2 Cre Recombinase-induced GFP expression (white arrows) is
coincident with COUP-TFII expression (yellow arrows). The merged image
shows COUP-TFII and GFP colocalization (white arrowheads) in adult Leydig
stem cells. (Lower) In adulthood, fetally induced YFP expression (white ar-
row) is restricted to 3β-HSD–expressing (yellow arrow) adult Leydig cells,
which is indicated by their coexpression (white arrowhead in merged
image). Images are representative of three to five animals from two in-
dependent experiments. (Scale bars: 20 μm.)
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found between ArKO and WT adult mice (Fig. 9). This increased
H3K27me3 immunoexpression may not be restricted to StAR,
but consistent with the hypothesized fetal origin of the change in
H3K27me3 localization to the StAR promoter in testes of DBP-
exposed animals, we found localization of H3K27me3 to adult
Leydig stem (COUP-TFII+) cells in the fetal testes of DBP-
exposed rats, whereas no/minimal expression was detectable in
stem cells in controls at this antibody dilution (Fig. 9). In contrast,
immunoexpression of unmodified histone 3 was comparable in
control and DBP-exposed animals (Fig. S5). These observations
provide a potential mechanism (i.e., H3K27me3) through which
deficiency in fetal androgen action on stem cells could reprogram/
compromise adult Leydig cell function by altering transcription
of StAR.
Discussion
Fetal programming of testosterone levels/Leydig cell function in
adult men is conceptually important because of its close in-
terrelationship with common diseases that impair quality and
length of life in men. Although there is indirect supporting evi-
dence for fetal programming of adult testosterone levels (reviewed
in ref. 16), a limiting factor is the absence of direct evidence for
a mechanism to explain how adult Leydig cells, which do not
appear until puberty, could be affected (programmed) by fetal
events. The present findings provide this evidence in animal
studies by (i) identifying a population of (COUP-TFII–expressing)
stem cells from which adult Leydig cells differentiate, (ii) showing
that these cells are numerous in the fetal testis and conserved
across species, (iii) showing that these cells are androgen targets,
and (iv) showing that fetal deficits in intratesticular levels/action
impair development of these stem cells, resulting in impaired
function of the adult Leydig cells that differentiate from them. An
epigenetic mechanism that might explain this long-range pro-
gramming through altered H3K27me3 of the StAR promoter is
also shown.
Our initial goal, inspired by the KO studies by Qin et al. (30),
was to identify if COUP-TFII–expressing non-Leydig interstitial
cells were stem cells for adult Leydig cells. Using EDS-induced
adult Leydig cell ablation, we show that the new generation
of adult Leydig cells differentiates from among the population of
COUP-TFII–expressing, undifferentiated, spindle-shaped interstitial
cells. These cells, which we have termed adult Leydig stem cells, do
not express classical Leydig cell markers (LH receptor, steroidogenic
factor-1, steroidogenic enzymes, and INSl3) but express COUP-TFII
and AR, which they share with adult Leydig cells (although neither
of these markers is Leydig cell-specific). Based on comparative
phenotyping of the stem cells and newly differentiating Leydig cells
after EDS, switching on of the transcription factor GATA4 and
probably, PDGFRα seems to be a key early differentiation step, and
thereafter, these GATA4+/COUP-TFII+ cells switch on classic
Leydig cell markers, such as 3β-HSD and INSl3. We show that this
differentiation pattern recapitulates what happens during normal
puberty in the rat. GATA4 is important for differentiation of fetal
Leydig cells (34), which also derive from COUP-TFII–expressing
interstitial cells (33). GATA4 may also be imperative for de-
velopment of adult Leydig cells (52), because it induces expression
of steroidogenic factor-1 and StAR (53). Our findings are consistent
with previous reports of GATA4 expression in adult Leydig cells in
humans and rats (27, 35, 36) as well as in adult Leydig stem cells
(27). Expression of PDGFRα was not explored in detail in our
studies, but our findings and previous studies (27, 29) point to
a similar pattern and timing of expression in the adult Leydig stem
cells, which was detailed for GATA4. Our interpretation is that
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Fig. 5. Effect of complete ArKO in mice on numerical development and
function of adult Leydig cells and their stem cells. (A) Adult Leydig stem cells
(COUP-TFII+/3β-HSDneg) and (B) adult Leydig cells (COUP-TFII+/3β-HSD+) in
ArKO mice were quantified. Plasma hormone levels in adulthood as a mea-
sure of adult Leydig cell function are shown for (C) LH, (D) testosterone, and
(E) the LH to testosterone ratio. Values are means ± SEMs for n = 7–10 WT
and ArKO mice at each age. *P < 0.05, **P < 0.01, ***P < 0.001 compared
with respective (control) WT value.
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Fig. 6. DBP-induced reduction in fetal ITT alters numerical development of
adult Leydig stem cells and results in compensated Leydig cell failure in
adulthood. (A) ITT levels and (B) adult Leydig stem cells (COUP-TFII+/3β-
HSDneg) at e21.5 in relation to numerical development of (C) adult Leydig
stem cells and (D) adult Leydig cells (COUP-TFII+/3β-HSD+) postnatally through to
adulthood. Plasma hormone levels in adulthood as a measure of adult Leydig
cell function are shown for (E) LH, (F) testosterone, and (G) the LH to testos-
terone ratio. Values are means ± SEMs for n = 6–8 rats in each group. *P < 0.05,
**P < 0.01, ***P < 0.001 compared with respective (control) vehicle value.
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PDGFRα and GATA4 are switched on in the stem cells only when
they commence differentiation down the adult Leydig cell pathway
(i.e., become progenitors), because few, if any, of the (COUP-TFII+)
stem cells in the fetal testis express either GATA4 or PDGFRα. It
is unclear if the complete population of COUP-TFII–expressing
stem cells can develop into adult Leydig cells or only a subpop-
ulation, because only a proportion of the stem cells switched on
GATA4 or PDGFRα after EDS.
Previous studies suggested that adult Leydig cells could orig-
inate from other interstitial cell types, such as peritubular myoid
cells, pericytes, endothelial cells, or macrophages (24, 29, 54–56).
Using specific markers for these cell types and the EDS model,
we found no evidence for coexpression of COUP-TFII in these
cell types. Therefore, because the majority of normal and regen-
erating adult Leydig cells expresses COUP-TFII, we concluded
that development of adult Leydig cells from these other cell types,
although possible, is probably not the main mechanism. This con-
clusion is supported by our lineage tracing experiment. In keeping
with earlier studies (27, 29, 57), we noted that adult Leydig cells
commonly derive from (COUP-TFII+) cells that border the sem-
iniferous tubules, although in contrast to other studies (29), we did
not find any cells coexpressing the peritubular myoid (PTM) cell
marker SMA, COUP-TFII, and early Leydig cell markers. How-
ever, our findings do not exclude the possibility that, after EDS
treatment, regenerating adult Leydig cells could also derive from
interstitial cells that have dedifferentiated (e.g., pericytes that have
switched off CD146 or PTM cells that have switched off SMA) and
then either switched on COUP-TFII (pericytes) or maintained
their COUP-TFII expression (PTM cells).
Our results show an abundance of adult Leydig stem cells in
the fetal testes of four species, including humans, and that most
of these cells coexpress AR; similar cells are present in the adult
testes of these species together with COUP-TFII–expressing
adult Leydig cells. Our data show that, in fetal life, these stem
cells increase >17-fold in number from e15.5 to e21.5 in rats
when intratesticular testosterone levels are high/increasing (33, 40).
Moreover, KO of Ar in this cell type (and in all other cells;
ArKOs) in mice or experimental lowering of intratesticular tes-
tosterone in rats throughout this period (DBP exposure) both
resulted in ∼40% reduction in numbers of adult Leydig stem
cells around birth. This finding suggests that androgens positively
regulate proliferation of the stem cells. In both of our experi-
mental situations involving deficient fetal androgen action, the
resulting decrease in stem cell number persisted through to
adulthood, despite the fact that puberty was associated with a
marked and parallel increase in stem cell number in control and
treated rats and mice. This observation indicates that factors
other than androgens play an important role during puberty in
determining adult Leydig stem cell proliferation/number. The
increase in COUP-TFII–expressing stem cells during puberty is
consistent with an earlier study that quantified mesenchymal
non-Leydig interstitial cells based on morphology (22).
We anticipated that a developmental deficit in adult Leydig
stem cells might lead to reduced adult Leydig cell number. Al-
though such a reduction was the case in ArKOs, normal numbers
of adult Leydig cells developed in DBP-exposed rats in which
androgen levels/action had been reduced just in fetal life. One
explanation for this difference in outcome, despite the similarity
in shortfall of adult Leydig stem cells, is that KO of Ar in other
testis cell types in ArKO mice caused additional effects on adult
Leydig cell differentiation. Indeed, because SCArKO mice (de-
ficient in SCAr) also exhibit a numerical deficit in adult Leydig
cells as well as ArKOs (58), it is a potential explanation. Never-
theless, the absence of any significant effect on adult Leydig stem
cell numbers in SCArKO or PTMArKO (deficient in PTMAr)
mice [but their reduction in ArKOs (which lack AR also in the
adult Leydig stem cells) and DBP-exposed rats] emphasizes the
importance of androgen action on the stem cells. In this regard, we
cannot exclude the possibility that the fetal reduction in adult
Leydig stem cells is secondary to reduced Sertoli cell number (as
a result of androgen deficiency); as such, a reduction is evident in
both ArKO mice and DBP-exposed rats at birth (59).
In both models in which there was a fetal deficit in androgen
levels/action, there was compensated adult Leydig cell failure
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Fig. 7. Effect of prenatal DBP exposure on adult Leydig cell function as
monitored by expression of Leydig cell-specific genes in the steroidogenic
pathway. The testosterone synthesis cascade is shown at the top starting with
the LH receptor (Lhcgr) and finishing with 17β-hydroxysteroid dehydrogenase
type 3 (17β-hsd3). (A) LHcgr, (B) Star, (C) Cyp11a1, (D) 3β-hsd, (E) Cyp17a1, (F)
17β-hsd3. Because testis cellular composition was affected by treatment (loss of
germ cells and their mRNA in cryptorchid testes) in some DBP-exposed animals,
gene expression has been expressed relative to Sox9 expression in the same
testis (in the text). Values are means ± SEMs for n = 11–12 rats in each group.
*P < 0.05, **P < 0.01 compared with respective (control) vehicle.
A B
Fig. 8. Effect of prenatal DBP exposure on H3K27me3 in the proximal
promoter of StAR. The schematic shows the StAR promoter region targeted
(−85 bp) and amplified by PCR using primers as outlined (167 bp in length).
Levels of H3K27me3 were increased at the proximal promoter of StAR,
which was analyzed by ChIP (A) and densitometric assessment of PCR
products (B). Normal rabbit IgG was used as the negative control. Data were
calculated using the percentage total genomic input method. The input DNA
threshold cycle value (i.e., DNA that did not undergo immunoprecipitation)
was used to normalize the ChIP data. The average threshold cycle for trip-
licate assays was used in all subsequent calculations. Values are means ± SEMs
for n = 3 per group. **P < 0.01 compared with (control) vehicle.
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defined as normal/reduced blood testosterone in the face of el-
evated LH and thus, an altered LH to testosterone ratio (7, 60).
Because adult Leydig cells develop from the stem cells, this
finding implies that the stem cells are modified functionally as
well as numerically because of reduced fetal androgen exposure,
and this ultimately translates in adulthood into compromised
steroidogenesis. Based on results from the DBP rat model, a po-
tential explanation is reduced expression of StAR, which contributes
to regulating the import of cholesterol into the mitochondrion,
the rate-limiting step for testosterone production (42–44). Ex-
pression of other genes involved in Leydig cell steroidogenesis
was unaffected by in utero DBP exposure apart from 3β-hsd,
which was also decreased, but this change might not be expected to
significantly impact steroidogenesis, because it is not considered
rate-limiting.
To investigate a potential mechanism for reduced expression
of StAR, we hypothesized that it was because of histone mod-
ifications in its proximal-1 promoter region, which are important
in its regulation (45–47). Using ChIP, we showed that H3K27me3
upstream of the coding region of StAR, which is associated with
transcriptional repression (47, 49–51), was increased in testes of
DBP-exposed rats. Consistent with this finding, we found in-
creased immunoexpression of H3K27me3 in adult Leydig cells of
DBP-exposed rats and their stem cells in fetal life. A similar in-
crease in H3K27me3 immunoexpression in adult Leydig cells of
ArKOs is consistent with it being because of (fetal) androgen de-
ficiency rather than DBP exposure. Altered H3K27me3 of the
StAR proximal promoter region in stem cells in fetal life potentially
explains the compensated Leydig cell failure of DBP-exposed rats
in adulthood. In this regard, two other facts are important. First,
H3K27me3 is propagated through cell divisions (61, 62); therefore,
it is reasonable to suppose that H3K27me3-induced modification
of the StAR promoter in adult Leydig stem cells in fetal life would
be transmitted through to adulthood, despite the huge proliferative
changes that occur in stem cells pre- and postnatally. Second, LH is
a positive regulator of StAR (47, 63, 64), and therefore, our finding
that StAR expression is reduced in adulthood in testes of DBP-
exposed rats, despite elevated blood LH levels (and normal Lhr
expression), is additional indirect evidence that altered re-
sponsiveness of StAR has occurred. However, our studies do not
rule out that other epigenetic factors might be altered that could
also lead to altered expression of StAR or 3β-hsd.
Alternative explanations for our observations are possible. For
example, fetal phthalate exposure of rats has been shown to alter
adrenal function in adulthood (65), which may secondarily alter
Leydig cell function (66). We cannot exclude this possibility as a
contributory factor in our DBP studies, although it would not
explain the similar changes observed in ArKO mice.
Our finding that fetal deficits in androgen action can result
in compromised adult Leydig cell function in rodents fits with
emerging evidence from humans (14, 16). There is a similar
connection between reduced fetal androgens and reduced adult
sperm counts/sperm production in men and rats (15, 16). What
further ties these observations together is that men with low sperm
counts commonly exhibit compensated adult Leydig cell failure,
although why is unknown (18, 60, 67). It has been suggested that it
may be indicative of a common underlying (fetal) cause (18), and
our present animal experimental studies provide direct supporting
evidence for this suggestion. This suggested connection has wide-
spread implications, because one in six young men in northern
European countries has a low sperm count (<20 million/mL) (68),
and testosterone levels in men of all ages are declining (4–6).
Moreover, it has implications for morbidities associated with aging
and the aging-related decline in testosterone levels (3, 7–9, 69),
because ∼10% of aging men exhibit compensated Leydig cell
failure (7). Our findings also provide a pathway through which fetal
growth/birth weight could influence testosterone levels in adult
men (13), because no explanation for this association is currently
available. Finally, our findings add a new dimension to the sub-
stantial body of evidence (16) by showing how deficits in fetal
androgen exposure lead to a range of adverse changes in re-
productive function and disorders in boys/men.
Materials and Methods
Animals and Treatments. Selective destruction of Leydig cells in adultWistar rats
used a single i.p. injection of EDS [75mgEDS/kg in 2mL/kgDMSO:water (1:3; vol:
Fig. 9. Effect of fetal DBP exposure or ArKO on H3K27me3 expression in
adult Leydig cells and their stem cells in the rat/mouse testis. (Row 1) A
proportion of adult Leydig stem cells (yellow arrows) coexpresses COUP-TFII
(green) and H3K27me3 (red) in their nuclei in DBP-exposed rats at e21.5
(Center and Right), whereas in controls, H3K27me3 was detected only in
Sertoli cells at this antibody concentration (Left). (Rows 2–4) During puberty
(Pnd25) and adulthood, adult Leydig cells (3β-HSD+; red cytoplasmic staining)
in DBP-exposed rats or ArKO mice expressed higher levels of H3K27me3 in
their nuclei (green; white arrows) compared with controls, in which it was
minimal/absent (Left). Images are representative of three to five animals for
each group for three independent experiments. (Scale bars: 20 μm.)
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vol)] (31, 32); control rats received vehicle. Rats weremaintained under standard
controlled conditions according to United Kingdom Home Office Guidelines
(including an ethical approval step) and fed a soy-free breeding diet [RM3 (E)
soya free; SDS]. Groups of five to seven vehicle- and EDS-treated rats were
killed at 6, 14, 21, and 35 d after injection. To investigate if reduced fetal
testosterone levels affect development of adult Leydig stem cells, time-mated
pregnant rats were administered DBP (Sigma-Aldrich) at 500 mg/kg per day by
oral gavage in 1 mL/kg corn oil from e13.5 to e21.5. This treatment reduces
fetal intratesticular testosterone by 40–80% (33). Groups of 6–12 vehicle- and
DBP-exposed rats were killed at e21.5 and Pnd6, -10, -15, -25, and -75.
Human, Marmoset, and Mouse Fetal Testis Tissue. Second trimester (14–18 wk)
human fetal testes were obtained after termination of pregnancy. Women
gave consent in accordance with United Kingdom national guidelines (70),
and ethical approval was obtained from the local research ethics committee
(71). Marmoset fetal testes (72) and mouse fetal testes (e18.5) (33) were
obtained as described earlier.
Lineage Tracing of Adult Leydig Stem Cells. Male congenic C57BL/6J mice
hemizygous for an aP2-Cre transgene (37) were mated to homozygous R26R-
EYFP females (73). The +/aP2-Cre:+/R26R-EYFP and +/+:+/R26R-EYFP (control)
male offspring from these matings were genotyped as previously described (38).
Generation of ArKO Mice. ArKO mice were generated (58) by crossing Arflox/+
females with phosphoglycerate kinase-1–Cre+/+ males. Animals were treated
according to the Care and Use of Laboratory Animals of the Catholic University
of Leuven with approval by the local ethics committee. Groups of 5–11WT and
ArKO males were killed on Pnd2, -12, -20, -50, and -140.
Tissue Collection and Processing. Animals were killed by CO2 inhalation and
cervical dislocation. In adults, blood was collected by cardiac puncture into
a heparinized syringe. Testes were dissected, weighed, and either frozen for
RNA analysis or fixed in Bouins (6 h) before processing into paraffin wax (33).
Sections (5 μm) were mounted on charged microscope slides (VWR) and
dried overnight at 50 °C.
Immunohistochemical Analysis. Immunostaining was for two to three proteins
to delineate cell types for analysis using methods and antibodies validated
previously (33, 41). Slides were dewaxed and rehydrated and underwent
heat-induced antigen retrieval (33). Sections were blocked using 20% nor-
mal rabbit serum (vol/vol; Biosera) and 5% BSA (wt/vol; Sigma-Aldrich) in
Tris-buffered saline (TBS). Secondary antibodies were diluted 1:500 in sera
(Table S1). Slides were incubated for 30 min with Streptavidin-alkaline
phosphatase (Vector) at 1:200 in TBS. Fast blue and red were used for
protein detection (Perma Blue/Red; Diagnostic BioSystems) followed by
antigen retrieval for 2.5 min on medium heat. Sections were reblocked in
serum/TBS/BSA as above before application of (second) primary antibody
followed by repetition of the above process. Streptavidin-HRP (Dako) at
1:1,000 in TBS was used for detection of biotinylated secondaries (1:500) in
TBS. Detection used 3,3-diaminobenzidine tetrahydrochloride (Dako). Slides
were mounted with Permafluor (Thermo Scientific). Each immunohisto-
chemistry run included negative controls, with replacement of the primary
antibody by blocking serum or preabsorption (PDGFRα) by incubation at
4 °C overnight with 10× immunogen concentration (Santa Cruz) (Fig. S6).
Sections from control and treatment groups were mounted on the same
slide where possible; each experiment used sections from three to six animals
per group/age. For immunofluorescence, primary and secondary antibodies
were diluted as optimized (Table S1). Detection used tyramide (Tyr-Cy3/5;
Perkin-Elmer-TSA-Plus Cyanine3/5 System; Perkin-Elmer Life Sciences) for 10
min (1:50) in its buffer. Nuclear counterstain (DAPI; Sigma-Aldrich) was diluted
1:500 in TBS and incubated for 10 min. For colocalization, normal chicken
serum was used as blocking serum to prevent cross-reaction with mouse/rab-
bit/goat antibodies, and the protocol was continued as before. Fluorescent
images were captured using the laser scanning confocal microscope 710 Axi-
overt Observer Z1 (Carl Zeiss). Images were compiled using Photoshop 7.0
(Adobe Systems Inc.).
Identification of Testis Cell Types. Leydig cells were identified as cells
immunopositive for 3β-HSD. SMA distinguished peritubular myoid cells and
defined seminiferous cords/tubules. Macrophages, pericytes, and endothelial
cells were identified using specific markers (Table S1). COUP-TFII+ interstitial
cells immunonegative for the aforementioned cell-specific markers were
considered adult Leydig stem cells.
Quantification of Adult Leydig Cells and Adult Leydig Stem Cells. Numbers per
testis of COUP-TFII+ adult Leydig stem cells and adult Leydig cells were de-
termined by stereology (33, 41). A Zeiss Axio-Imager microscope (Carl Zeiss)
fitted with a Hitachi HVC20 camera (Hitachi Denshi Europe) and a Prior au-
tomatic stage (Prior Scientific Instruments Ltd.) was used plus Image-Pro Plus
v7.0 with Stereologer Analyzer Pro (Media Cybernetics). Using random fields,
testis cross-sections were analyzed for COUP-TFII+/3β-HSDneg adult Leydig stem
cells and adult Leydig cells (3β-HSD+) and expressed as relative volumes per
testis before conversion to absolute volumes using testis weight; then, they
were converted to cell number per testis using the average nuclear diameter
(∼150 nuclei) measured for each sample, group, and age (33, 41).
RNA Extraction. Total RNA was isolated from frozen testes using the RNeasy
Mini Extraction Kit with RNase-Free DNase (Qiagen) as per themanufacturer’s
instructions. RNA quality and concentration were determined using a
Nanodrop ND-1000 spectrophotometer (Thermo Scientific). Random hex-
amer primed cDNA was prepared using SuperScript VILO cDNA (Invitrogen)
as per the manufacturer’s instructions and stored at −20 °C.
Quantitative Gene Expression Analysis. Quantitative PCR was performed for
genes (Table S2) using an ABI Prism 7900 HT Sequence Detection System (Applied
Biosystems) and optimized standard conditions and probes (Roche Universal
Probe Library), and it was expressed relative to internal 18s control (quantified
using the ΔΔthreshold cycle method). The mean of triplicates per sample was
determined and standardized relative to adult control testis (Ambion).
Hormone Analysis. Plasma LH and testosterone were measured using assays
detailed previously (33, 74). All samples from each experiment were run in
a single assay, and the within-assay coefficients of variation were <10%.
ChIP Assay. Testis tissue (150mg) from adult control andDBP-exposed rats was
suspended in PBS and incubated with 37% (vol/vol) formaldehyde (270 μL) for
10 min before quenching with glycine (250 μL 2.5 M; Sigma-Aldrich). After
centrifugation, the pellet was resuspended in PBS and protease inhibitor
mixture (Roche Complete) and homogenized (T10 Basic Ultra-Turrax; IKA).
Samples were sonicated using a Bioruptor (Diagenode) to shear chromatin
to 200–1,000 bp before diluting 10-fold in immunoprecipitation dilution
buffer [0.1% SDS, 1.1% Triton-X (wt/vol), 1.2 mM EDTA, 16.7 mM Tris·HCl,
167 mM NaCl]. An aliquot (1%) was saved for input control. Samples were
precleaned using salmon sperm DNA/Protein Agarose A (Millipore) for 30 min
at 4 °C with rotation and then incubated overnight (with rotation at 4 °C) with
H3K27me3 antibody, rabbit IgG (27472; Abcam) as negative control, or anti-
histone 3 (Table S1) as positive control. Samples were incubated with salmon
sperm DNA/Protein Agarose A for 4 h at 4 °C. After centrifugation, precipitates
were washed for 10 min with solutions of low salt (0.1% SDS, 1% Triton-X,
2 mM EDTA, 20 mM Tris·HCl, 150 mM NaCl), high salt (0.1% SDS, 1% Triton-X,
2 mM EDTA, 20 mM Tris·HCl, 500 mM NaCl), lithium chloride (1 mM EDTA, 10
mM Tris·HCl, 1% Deoxycholic acid, 1% Igepal ca630, 0.25 M LiCl), and Tris-
ethylendiaminetetraacetic acid buffer (1 mMEDTA, 10 mM Tris·HCl). Chromatin
was eluted in 1% SDS and 0.1 M NaHCO3. NaCl (8 μL 5 M) was added to the
eluate and incubated overnight at 4 °C to reverse cross-links before incubating
with 0.5 M EDTA, 1 M Tris·HCL, and proteinase K for 60 min at 45 °C. Purified
DNA from samples, including input control, was recovered (QIAquick PCR
Purification Kit; Qiagen). Primers for the proximal upstream promoter of StAR
(167 bp) (Table S2) were used for PCR using SYBR GreenMaster Mix (Brilliant III
Ultrafast; Agilent Technologies). PCR products were visualized by 2% agarose
gel electrophoresis followed by densitometric analysis using ImageJ (version
1.46h; National Institutes of Health).
Statistical Analysis.DatawereanalyzedbyGraphPadPrism(version5;GraphPad
Software, Inc.) using ANOVA followed by either posthoc Bonferroni or Student
t tests as appropriate. Where significant heterogeneity of variance occurred
(e.g., plasma testosterone), values were log-transformed before analysis.
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